Mifepristone Access Imperiled By Supreme Court’s Draft Decision Overturning Abortion Rights
Executive Summary
Clinicians in states that ban abortion could face criminal prosecution for providing mifepristone. Access to medical abortion ‘is not a panacea’ if the court overrules Roe v. Wade as people using the drug face risks from aggressive prosecutors, ACLU attorney says.
You may also be interested in...
US FDA May Play Central Role In Assuring Access To Mifepristone Post Roe v. Wade
HHS will take steps to increase access to abortion medication and prevent states from banning it, Secretary Becerra says, but also is questioned about whether the FDA can speed up certification of pharmacies and if the Justice Department would sue states banning access.
Likely Limits On Reproductive Rights Drive Democrats’ Urgency For OTC Oral Contraceptive
Sponsors in both chambers amplify the FDA’s role announcing the legislation, saying the bills intend to “maintain the FDA’s sole authority to determine the safety and efficacy of drugs and make them available over-the-counter without a prescription.”
Republicans Turn Their Backs On Califf
A visual comparison of Robert Califf’s US FDA Commissioner confirmation votes in 2016 and 2022.